Oleksandr Oleksandrovich Nefodov

Prof. Dr. Oleksandr Oleksandrovich Nefodov

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
MJMonika Jokubaite
Monika Jokubaite
MMMindaugas Marksa
Mindaugas Marksa
ONOleksandr Oleksandrovich Nefodov
Oleksandr Oleksandrovich Nefodov
TSTetiana Sakharova
Tetiana Sakharova
KRKristina Ramanauskienė
Kristina Ramanauskienė
Propolis is a widely studied natural raw material, the composition of which varies depending on the plant origin, harvest season, geographical area, climate and bee species. This large variety of chemical composition limits the use of propolis extracts in the pharmaceutical industry, which makes it difficult to ensure standardization of the raw material. One of the challenges that limit the modeling of oral pharmaceutical forms with propolis extract is the limited solubility and bioavailability of active compounds. Solid dispersion technology is commonly used in the production of oral capsules. The aim of this study is to evaluate the influence of different materials (HPMC, poloxamer and β-cyclodextrin) on the dissolution kinetics of phenolic compounds of propolis dry extract contained in capsules and their antioxidant activity in vitro. Analysis of the selected formulations showed that the major phenolic compounds detected in the propolis extract were also present in the dissolution medium samples. The auxiliary polymeric materials selected for the capsules formed a prerequisite for the dissolution kinetics profile. The addition of poloxamer and cyclodextrin increased the solubility and dissolution kinetics of hydrophobic propolis compounds in the test media. The addition of HPMC prolonged the dissolution kinetics of propolis active compounds. The antioxidant activity of the tested samples depends on the concentration of active compounds in the receptor medium by both the ABTS and DPPH methods.

20 July 2026 in Gels
Verified
Journal Article
Open access
PDF file
DSDovile Svetikiene
Dovile Svetikiene
VAVita Ambrulaitiene
Vita Ambrulaitiene
GJGintarė Jančiukė
Gintarė Jančiukė
ISIeva Sarapinienė
Ieva Sarapinienė
GZGintaras Zamokas
Gintaras Zamokas
KRKristina Ramanauskienė
Kristina Ramanauskienė
Eye diseases are common in veterinary clinical practice and are most often treated with topical ophthalmic preparations. Increasing resistance to antimicrobial agents is driving the search for safe and effective alternatives to traditional treatment methods. The aim of this study was to develop and evaluate gel-based ophthalmic formulations based on poloxamer 407 and sodium carboxymethylcellulose, containing propolis extracts and diclofenac sodium, by assessing their physical and chemical properties, antimicrobial activity, and cytotoxicity in vitro. Propolis extracts were prepared using a solvent consisting of ethanol and choline chloride, and the developed formulations were evaluated for pH, viscosity, refractive index, gelation temperature, SIRC cell viability and apoptosis, and antimicrobial activity against clinical and reference bacterial strains. The developed formulations exhibited physicochemical properties suitable for ophthalmic preparations and antimicrobial activity, particularly against Gram-positive bacteria. Most of the concentrations of the active ingredients tested were well tolerated by SIRC cells, although higher concentrations of the ethanol propolis extract caused a greater cytotoxic effect. The results obtained indicate that gelled ophthalmic formulations based on propolis extracts and diclofenac sodium are promising for the further development of topically acting ophthalmic preparations; however, their biological efficacy and safety must be confirmed. The results obtained indicate that gelled ophthalmic formulations based on propolis extracts and diclofenac sodium are promising for the further development of topical ophthalmic preparations; however, their bioavailability and safety must be confirmed by further in vivo studies.